Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma

References

• Wendler F, Stamp GW, Giamas G. Tumor-stromal cell communication: small vesicles signal big changes. Trends Cancer. 2016 Jul;2(7):1–14.
   Web of Science ®Google Scholar
• Keller S, Ridinger J, Rupp AK, et al. Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med. 2011;9:86.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. Tumor-derived Exosomes and their role in tumor-induced immune suppression. Vaccines (Basel). 2016 Oct 20;4:4.
   Web of Science ®Google Scholar
• Whiteside TL. Exosomes and tumor-mediated immune suppression. J Clin Invest. 2016 Apr 1;126(4):1216–1223.
   PubMed Web of Science ®Google Scholar
• Valenti R, Huber V, Iero M, et al. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res. 2007 Apr 1;67(7):2912–2915.
   PubMed Web of Science ®Google Scholar
• Wieckowski EU, Visus C, Szajnik M, et al. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J Immunol. 2009 Sep 15;183(6):3720–3730.
   PubMed Web of Science ®Google Scholar
• Peinado H, Aleckovic M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012 Jun;18(6):883–891.
   PubMed Web of Science ®Google Scholar
• Koliha N, Wiencek Y, Heider U, et al. A novel multiplex bead-based platform highlights the diversity of extracellular vesicles. J Extracell Vesicles. 2016;5:29975.
   PubMed Web of Science ®Google Scholar
• Li P, Kaslan M, Lee SH, et al. Progress in Exosome Isolation Techniques. Theranostics. 2017;7(3):789–804.
   PubMed Web of Science ®Google Scholar
• Hong CS, Funk S, Muller L, et al. Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles. 2016;5:29289.
   PubMed Web of Science ®Google Scholar
• Campoli MR, Chang CC, Kageshita T, et al. Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance. Crit Rev Immunol. 2004;24(4):267–296.
   Web of Science ®Google Scholar
• Wang X, Katayama A, Wang Y, et al. Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4. Cancer Res. 2011 Dec 15;71(24):7410–7422.
   PubMed Web of Science ®Google Scholar
• Schlingemann RO, Rietveld FJ, de Waal RM, et al. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol. 1990 Jun;136(6):1393–1405.
   Web of Science ®Google Scholar
• Wang Y, Sabbatino F, Wang X, et al. Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma. Method Mol Biol. 2014;1102:523–535.
   PubMedGoogle Scholar
• Temponi M, Gold AM, Ferrone S. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab’ fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen. Cancer Res. 1992 May 1;52(9):2497–2503.
   Web of Science ®Google Scholar
• Morales-Kastresana A, Jones JC. Flow cytometric analysis of extracellular vesicles. Method Mol Biol. 2017;1545:215–225.
   PubMedGoogle Scholar
• Koliha N, Heider U, Ozimkowski T, et al. Melanoma affects the composition of blood cell-derived extracellular vesicles. Front Immunol. 2016;7:282.
   Web of Science ®Google Scholar
• Atay S, Godwin AK. Tumor-derived exosomes: a message delivery system for tumor progression. Commun Integr Biol. 2014 Jan 1;7(1):e28231.
   PubMedGoogle Scholar
• Melo SA, Luecke LB, Kahlert C, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015 Jul 9;523(7559):177–182.
   PubMed Web of Science ®Google Scholar
• Matei I, Kim HS, Lyden D. Unshielding exosomal RNA unleashes tumor growth and metastasis. Cell. 2017 Jul 13;170(2):223–225.
   Web of Science ®Google Scholar
• Whiteside TL. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans. 2013 Feb 1;41(1):245–251.
   PubMed Web of Science ®Google Scholar
• Muller L, Mitsuhashi M, Simms P, et al. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep. 2016;6:20254.
   PubMed Web of Science ®Google Scholar
• Whiteside TL. The potential of tumor-derived exosomes for noninvasive cancer monitoring. Expert Rev Mol Diagn. 2015 Aug;2:1–18.
   Google Scholar
• Hong CS, Muller L, Boyiadzis M, et al. Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PloS One. 2014;9(8):e103310.
   PubMed Web of Science ®Google Scholar
• Fang S, Tian H, Li X, et al. Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PloS One. 2017;12(4):e0175050.
   PubMed Web of Science ®Google Scholar
• Khan S, Jutzy JM, Valenzuela MM, et al. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PloS One. 2012;7(10):e46737.
   PubMed Web of Science ®Google Scholar
• Logozzi M, Angelini DF, Iessi E, et al. Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients. Cancer Lett. 2017 Sep;10(403):318–329.
   Google Scholar
• Logozzi M, de Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PloS One. 2009;4(4):e5219.
   PubMed Web of Science ®Google Scholar
• Zarovni N, Corrado A, Guazzi P, et al. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods. 2015 Oct;01(87):46–58.
   Google Scholar